ClinicalTrials.gov
public full text
Public Domain
Activated Protein C and Microcirculation
Objective: to test the hypothesis that recombinant activated protein C (aPC) therapy improves the microcirculation of severe septic patients. Design: Prospective, open study. Setting: University 12-beds intensive care unit. Patients: Septic patients with at least two sepsis-induced organ failures occurring within 48 hours of the onset of sepsis were included in a one year period. Interventions: Patients who had no contraindication to aPC administration received aPC at a dose of 24 mcg/kg/h for 96 hours. Patients with contraindications to aPC infusion were considered as controls.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pathophysiology and Management of Sepsis-associated Acute Kidney Injury.#615762
- Resuscitation Strategies in Septic Shock#1030821
- Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality#1031540
- High Dose of Vitamin C on Mechanically Ventilated Septic Patients in Intensive Care Unit#1100364
- Early mobilization with or without cycloergometry in patients with septic shock in Intensive Care Unit: a randomized controlled trial#7736
Record · ID 1295845
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive